Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11

類似資料

• Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (irinotecan; CPT-11) toxicity
  著者:: Hicks, Latorya D., 等
  出版事項: (2009)
• Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones
  著者:: Parkinson, Elizabeth I., 等
  出版事項: (2011)
• Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors
  著者:: Tsurkan, Lyudmila G., 等
  出版事項: (2012)
• Analysis of the Inhibition of Mammalian Carboxylesterases by Novel Fluorobenzoins and Fluorobenzils
  著者:: Hicks, Latorya D., 等
  出版事項: (2007)
• Carboxylesterases: General detoxifying enzymes
  著者:: Hatfield, M. Jason, 等
  出版事項: (2016)